Soleno Therapeutics’ $60 Million Financing Commitment

Martina Bellini
Tagged:

Akin Gump represented Nantahala Capital Management on the deal.Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now